Replies to post #1936 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s pro forma cash @3/31/21=$426.1M—a decrease of $15.3M since 12/31/20 (#msg-161707561).

The $426.1.4M figure above consists of: $401.6M of net current assets on the 3/31/21 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/1177648/000156459021026025/enta-10q_20210331.htm#CONSOLIDATED_BALANCE_SHEETS ); and $24.5M of marketable securities on the 3/31/21 balance sheet designated as long-term (e.g. bonds with a time to maturity greater than one year).